1. Home
  2. SCLX vs BCG Comparison

SCLX vs BCG Comparison

Compare SCLX & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • BCG
  • Stock Information
  • Founded
  • SCLX 2011
  • BCG 2016
  • Country
  • SCLX United States
  • BCG United States
  • Employees
  • SCLX N/A
  • BCG N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • BCG
  • Sector
  • SCLX Health Care
  • BCG
  • Exchange
  • SCLX Nasdaq
  • BCG Nasdaq
  • Market Cap
  • SCLX 51.3M
  • BCG 42.3M
  • IPO Year
  • SCLX N/A
  • BCG N/A
  • Fundamental
  • Price
  • SCLX $4.06
  • BCG $2.27
  • Analyst Decision
  • SCLX Strong Buy
  • BCG
  • Analyst Count
  • SCLX 4
  • BCG 0
  • Target Price
  • SCLX $396.67
  • BCG N/A
  • AVG Volume (30 Days)
  • SCLX 103.2K
  • BCG 48.5K
  • Earning Date
  • SCLX 05-12-2025
  • BCG 05-26-2025
  • Dividend Yield
  • SCLX N/A
  • BCG N/A
  • EPS Growth
  • SCLX N/A
  • BCG N/A
  • EPS
  • SCLX N/A
  • BCG N/A
  • Revenue
  • SCLX $56,590,000.00
  • BCG $164,877,000.00
  • Revenue This Year
  • SCLX $115.30
  • BCG N/A
  • Revenue Next Year
  • SCLX $73.33
  • BCG N/A
  • P/E Ratio
  • SCLX N/A
  • BCG N/A
  • Revenue Growth
  • SCLX 21.07
  • BCG 1.25
  • 52 Week Low
  • SCLX $5.80
  • BCG $1.71
  • 52 Week High
  • SCLX $80.50
  • BCG $12.22
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 24.27
  • BCG N/A
  • Support Level
  • SCLX $3.60
  • BCG N/A
  • Resistance Level
  • SCLX $7.64
  • BCG N/A
  • Average True Range (ATR)
  • SCLX 1.21
  • BCG 0.00
  • MACD
  • SCLX -0.37
  • BCG 0.00
  • Stochastic Oscillator
  • SCLX 6.67
  • BCG 0.00

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About BCG Binah Capital Group Inc. Common Stock

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: